Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker

Bloomberg2021-08-19

Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock. Pfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

stephh
2021-08-19
stephh
Like and comment. Thanks.
- 137bd706:
  done likewise

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1113170668?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-19 10:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113170668","market":"us","top_or_hot":-1,"title":"Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker","media":"Bloomberg","content":"<div>\n<p>Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 10:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp","article_id":"1113170668","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113170668","pubTimestamp":1629340449,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer ","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"translate_title":"辉瑞取代莫德纳成为日内交易者最喜欢的疫苗制造商","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9,"PFE":0.9},"content_text":"Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about $63 million of the shares on Tuesday alone, according to data from Vanda Research. The day-trading crowd sold off more positions than they bought in Moderna and BioNTech.\nIt marks a sharp change in fortunes. Both Moderna and BioNTech have amassed triple digit gains this year, a rally the nearly $280 billion-valued Pfizer missed out on with a scant 34% gain, despite being the first -- along with BioNTech -- to win authorization for a Covid shot in the U.S. The U.S. announced today that it would start offering booster shots to the already vaccinated in September.\nAs Pfizer rallies, BioNTech has tumbled more than 18% from a record high reached on Aug. 9, while Moderna is down roughly 18% from its zenith. All three stocks slumped today, with Pfizer reversing early gains to close down 2.2%.\n\nPfizer’s stock now trades at about an 8% premium to the average analyst price target, compared to more than 30% for Moderna and 18% for BioNTech.\nThe recent closing of the gap may not spell the end of the rally. Wall Street is already adjusting its models with Pfizer getting a new Wall Street high price target of $61 from Cantor Fitzgerald analyst Louise Chen on Tuesday.\nThe drugmaker’s “pipeline advancements and product sales continue to exceed our expectations,” she wrote in a note to clients.","kind":"news","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":831483443,"gmtCreate":1629340732482,"gmtModify":1631893749215,"author":{"id":"3575058137963235","authorId":"3575058137963235","name":"stephh","avatar":"https://static.tigerbbs.com/7e248aeda9d24c835ab13541550241cf","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575058137963235","authorIdStr":"3575058137963235"},"htmlText":"Like and comment. Thanks.&nbsp;","listText":"Like and comment. Thanks.&nbsp;","text":"Like and comment. Thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/831483443","repostId":1113170668,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5574988,"gmtCreate":1629342328487,"gmtModify":1631893749216,"authorId":3584415246670106,"author":{"id":3584415246670106,"idStr":"3584415246670106","authorId":3584415246670106,"name":"137bd706","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":831483443,"type":1,"supId":0,"prevId":0,"content":"done likewise","text":"done likewise","html":"done likewise"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":47,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113170668"}